Hims shares have roughly doubled since the start of the year, despite the FDA’s announcement last week that Novo Nordisk’s ...
Shares of Hims & Hers Health (HIMS) sank in after-hours trading after the healthcare company reported earnings for its fourth quarter of ...
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended ...
Investor's Business Daily on MSN53m
IBD 50's No. 2, Hims & Hers, Crashes 15% Despite Upbeat EarningsCompounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback